{"transactions":[{"id":757526,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":42881,"kind":"person","name":"Soergel David","position":1,"cik":"0001591475","reported_name":"Soergel David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-01T23:49:09.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1042,"price":495.74,"value":516561.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2026."}],"balance_after":10033,"source":{"system":"sec-edgar","filing":"0001628280-26-039653","document":"wk-form4_1780357747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026039653/wk-form4_1780357747.xml","form_type":"4"}},{"id":775497,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":42881,"kind":"person","name":"Soergel David","position":1,"cik":"0001591475","reported_name":"Soergel David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:36:12.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":844,"price":515.9,"value":435419.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":11075,"source":{"system":"sec-edgar","filing":"0001628280-26-036078","document":"wk-form4_1779140170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026036078/wk-form4_1779140170.xml","form_type":"4"}},{"id":856460,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":42881,"kind":"person","name":"Soergel David","position":1,"cik":"0001591475","reported_name":"Soergel David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T22:55:58.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":5467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":5467,"derivative":{"exercise_price":434.8,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":5467},"source":{"system":"sec-edgar","filing":"0001628280-26-015722","document":"wk-form4_1772837756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015722/wk-form4_1772837756.xml","form_type":"4"}},{"id":856459,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":42881,"kind":"person","name":"Soergel David","position":1,"cik":"0001591475","reported_name":"Soergel David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:55:58.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":4374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":11919,"source":{"system":"sec-edgar","filing":"0001628280-26-015722","document":"wk-form4_1772837756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015722/wk-form4_1772837756.xml","form_type":"4"}},{"id":1145881,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":42881,"kind":"person","name":"Soergel David","position":1,"cik":"0001591475","reported_name":"Soergel David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-16T22:23:51.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":12839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (May 15, 2026) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":12839,"derivative":{"exercise_price":291.82,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":12839},"source":{"system":"sec-edgar","filing":"0001628280-25-026346","document":"wk-form4_1747434224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025026346/wk-form4_1747434224.xml","form_type":"4"}},{"id":1145880,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":42881,"kind":"person","name":"Soergel David","position":1,"cik":"0001591475","reported_name":"Soergel David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-05-16T22:23:51.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":7545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of May 15, 2026, May 15, 2027, May 15, 2028 and May 15, 2029, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":7545,"source":{"system":"sec-edgar","filing":"0001628280-25-026346","document":"wk-form4_1747434224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025026346/wk-form4_1747434224.xml","form_type":"4"}},{"id":4403699,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":42881,"kind":"person","name":"Soergel David","position":1,"cik":"0001591475","reported_name":"Soergel David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP,Clinical Dev. & CMO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-03T22:01:30.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable with respect to one-fourth of the total number of shares subject to the option on each of March 2, 2018, March 2, 2019, March 2, 2020 and March 2, 2021, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. 2013 Equity Incentive Plan, as amended) as of each such vesting date."}],"balance_after":91000,"derivative":{"exercise_price":4.13,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001209191-17-017703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117017703/doc4.xml","form_type":"4"}},{"id":4496292,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":42881,"kind":"person","name":"Soergel David","position":1,"cik":"0001591475","reported_name":"Soergel David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP,Clinical Dev. & CMO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-06T21:49:03.000Z","date":"2017-01-06","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable with respect to one-fourth of the total number of shares subject to the option on each of January 6, 2018, January 6, 2019, January 6, 2020 and January 6, 2021, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. 2013 Equity Incentive Plan, as amended) as of each such vesting date."}],"balance_after":55000,"derivative":{"exercise_price":6.61,"expiration_date":"2027-01-06","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-17-002674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117002674/doc4.xml","form_type":"4"}}]}